Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

Chris S. Hourigan, Kristin Page, Gege Gui et al.|Journal of Clinical Oncology|2022

Cited by 11